Can Human Embryonic Stem Cell-Derived Stromal Cells Serve a Starting Material for Myoblasts?
A large number of myocytes are necessary to treat intractable muscular disorders such as Duchenne muscular dystrophy with cell-based therapies. However, starting materials for cellular therapy products such as myoblasts, marrow stromal cells, menstrual blood-derived cells, and placenta-derived cells...
Saved in:
| Main Authors: | Yu Ando, Marie Saito, Masakazu Machida, Chikako Yoshida-Noro, Hidenori Akutsu, Masataka Takahashi, Masashi Toyoda, Akihiro Umezawa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2017/7541734 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stromal interaction molecule 2 regulates C2C12 myoblast differentiation
by: Tam Thi Thanh Phuong, et al.
Published: (2015-12-01) -
Establishment of reproducible method for production of cultured epidermal sheets with controlled melanocyte density
by: Mai Mori, et al.
Published: (2025-06-01) -
Late-onset pericarditis after autologous myoblast cell-sheet transplantation for ischemic cardiomyopathy
by: Ryotaro Matsuo, et al.
Published: (2025-06-01) -
Hyperthermia Differently Affects Connexin43 Expression and Gap Junction Permeability in Skeletal Myoblasts and HeLa Cells
by: Ieva Antanavičiūtė, et al.
Published: (2014-01-01) -
RCOR1 promotes myoblast differentiation and muscle regeneration
by: Martina Pauk, et al.
Published: (2025-07-01)